Beckman Coulter

(BEC)

, a maker of laboratory test kits and supplies, signed a two-year collaborative research and development agreement with the Research in Immune Tolerance in Transplantation program in Canada.

The research will be conducted in the RITT Industrial Biodevelopment Laboratory at the Toronto General Hospital.

Under the terms of the agreement, the Fullerton, Calif., company will receive the first rights to new discoveries. In turn, Beckman Coulter will support a postdoctoral research scientist position for two years, provide funding for the design and formulation of new reagent combinations, and offer additional assistance and sponsorships.

Additionally, the RITT program has agreed to acquire more than $1 million of separation and analysis equipment from Beckman Coulter.

Shares of Beckman Coulter fell 90 cents, or 1.7%, to $52.49 Thursday.

This story was created through a joint venture between TheStreet.com and IRIS.